ENSG00000196924 |
|
chronic myelomonocytic leukemia |
missense_variant |
3.158% (3/95) |
1 entry |
ENSG00000196924 |
|
small cell lung carcinoma |
frameshift_variant |
4.938% (16/324) |
2 entries |
ENSG00000196924 |
|
skin melanoma |
missense_variant |
2.689% (26/967) |
2 entries |
ENSG00000196924 |
|
rectal adenocarcinoma |
missense_variant |
3.084% (7/227) |
3 entries |
ENSG00000196924 |
|
breast ductal adenocarcinoma |
missense_variant |
2.995% (18/601) |
2 entries |
ENSG00000196924 |
|
lung adenocarcinoma |
stop_gained |
2.921% (34/1164) |
1 entry |
ENSG00000196924 |
|
Breast Carcinoma by Gene Expression Profile |
missense_variant |
10.53% (2/19) |
2 entries |
ENSG00000196924 |
|
small cell lung carcinoma |
missense_variant |
4.938% (16/324) |
4 entries |
ENSG00000196924 |
|
breast ductal adenocarcinoma |
sequence_alteration |
2.995% (18/601) |
2 entries |
ENSG00000196924 |
|
skin melanoma |
stop_gained |
2.689% (26/967) |
1 entry |
ENSG00000196924 |
|
prostate adenocarcinoma |
sequence_alteration |
0.2751% (4/1454) |
1 entry |
ENSG00000196924 |
|
gastric intestinal type adenocarcinoma |
missense_variant |
4.706% (4/85) |
2 entries |
ENSG00000196924 |
|
breast phyllodes tumor |
frameshift_variant |
34.88% (30/86) |
1 entry |
ENSG00000196924 |
|
colorectal adenocarcinoma |
stop_gained |
10.46% (119/1138) |
1 entry |
ENSG00000196924 |
|
colorectal adenocarcinoma |
frameshift_variant |
10.46% (119/1138) |
2 entries |
ENSG00000196924 |
|
HER2 Positive Breast Carcinoma |
missense_variant |
4.63% (5/108) |
1 entry |
ENSG00000196924 |
|
esophageal squamous cell carcinoma |
missense_variant |
2.074% (14/675) |
6 entries |
ENSG00000196924 |
|
small cell lung carcinoma |
sequence_alteration |
4.938% (16/324) |
2 entries |
ENSG00000196924 |
|
acute myeloid leukemia |
sequence_alteration |
0.7913% (8/1011) |
1 entry |
ENSG00000196924 |
|
central nervous system primitive neuroectodermal neoplasm |
missense_variant |
1.802% (8/444) |
2 entries |
ENSG00000196924 |
|
acute myeloid leukemia |
missense_variant |
0.7913% (8/1011) |
1 entry |
ENSG00000196924 |
|
clear cell renal carcinoma |
conservative_inframe_deletion |
0.895% (11/1229) |
2 entries |
ENSG00000196924 |
|
colon adenocarcinoma |
stop_gained |
5.163% (38/736) |
1 entry |
ENSG00000196924 |
|
hepatocellular carcinoma |
missense_variant |
1.44% (13/903) |
1 entry |
ENSG00000196924 |
|
breast phyllodes tumor |
conservative_inframe_deletion |
34.88% (30/86) |
1 entry |
ENSG00000196924 |
|
breast phyllodes tumor |
missense_variant |
34.88% (30/86) |
1 entry |
ENSG00000196924 |
|
head and neck squamous cell carcinoma |
missense_variant |
0.4792% (3/626) |
1 entry |
ENSG00000196924 |
|
gastric adenocarcinoma |
missense_variant |
3.405% (19/558) |
1 entry |
ENSG00000196924 |
|
colon adenocarcinoma |
frameshift_variant |
5.163% (38/736) |
2 entries |
ENSG00000196924 |
|
female breast carcinoma |
missense_variant |
2.247% (6/267) |
1 entry |
ENSG00000196924 |
|
basal cell carcinoma |
sequence_alteration |
20.69% (12/58) |
1 entry |
ENSG00000196924 |
|
esophageal adenocarcinoma |
missense_variant |
0.6849% (3/438) |
1 entry |
ENSG00000196924 |
|
esophageal squamous cell carcinoma |
sequence_alteration |
2.074% (14/675) |
2 entries |
ENSG00000196924 |
|
nasopharyngeal squamous cell carcinoma |
missense_variant |
1.198% (2/167) |
1 entry |
ENSG00000196924 |
|
lung adenocarcinoma |
missense_variant |
2.921% (34/1164) |
5 entries |
ENSG00000196924 |
|
Merkel cell skin cancer |
missense_variant |
10.0% (3/30) |
1 entry |
ENSG00000196924 |
|
Cervical Small Cell Carcinoma |
missense_variant |
33.33% (2/6) |
1 entry |
ENSG00000196924 |
|
melanoma |
stop_gained |
10.89% (11/101) |
1 entry |
ENSG00000196924 |
|
basal cell carcinoma |
missense_variant |
20.69% (12/58) |
1 entry |
ENSG00000196924 |
|
colon adenocarcinoma |
missense_variant |
5.163% (38/736) |
5 entries |
ENSG00000196924 |
|
lung adenocarcinoma |
sequence_alteration |
2.921% (34/1164) |
1 entry |
ENSG00000196924 |
|
Ampulla of Vater Carcinoma |
missense_variant |
2.353% (2/85) |
1 entry |
ENSG00000196924 |
|
squamous cell lung carcinoma |
missense_variant |
2.231% (17/762) |
1 entry |
ENSG00000196924 |
|
oral squamous cell carcinoma |
missense_variant |
2.439% (5/205) |
3 entries |
ENSG00000196924 |
|
breast carcinoma |
missense_variant |
1.559% (22/1411) |
1 entry |
ENSG00000196924 |
|
colorectal adenocarcinoma |
missense_variant |
10.46% (119/1138) |
4 entries |
ENSG00000196924 |
|
female breast carcinoma |
sequence_alteration |
2.247% (6/267) |
1 entry |
ENSG00000196924 |
|
melanoma |
missense_variant |
10.89% (11/101) |
2 entries |
ENSG00000196924 |
|
cecum adenocarcinoma |
missense_variant |
8.73% (11/126) |
1 entry |
ENSG00000196924 |
|
colorectal adenocarcinoma |
sequence_alteration |
10.46% (119/1138) |
3 entries |
ENSG00000196924 |
|
prostate carcinoma |
missense_variant |
0.7042% (3/426) |
1 entry |
ENSG00000196924 |
|
diffuse large B-cell lymphoma |
missense_variant |
1.316% (4/304) |
2 entries |
ENSG00000196924 |
|
skin melanoma |
sequence_alteration |
2.689% (26/967) |
1 entry |
ENSG00000196924 |
|
colon adenocarcinoma |
sequence_alteration |
5.163% (38/736) |
4 entries |
ENSG00000196924 |
|
gastric intestinal type adenocarcinoma |
frameshift_variant |
4.706% (4/85) |
1 entry |
ENSG00000196924 |
|
chronic myelomonocytic leukemia |
sequence_alteration |
3.158% (3/95) |
1 entry |
ENSG00000196924 |
|
Mixed Lobular and Ductal Breast Carcinoma |
missense_variant |
50.0% (1/2) |
1 entry |
ENSG00000196924 |
|
diffuse large B-cell lymphoma |
sequence_alteration |
1.316% (4/304) |
1 entry |
ENSG00000196924 |
|
Brain Stem Glioblastoma |
missense_variant |
1.786% (1/56) |
1 entry |
ENSG00000196924 |
|
rectal adenocarcinoma |
sequence_alteration |
3.084% (7/227) |
1 entry |
ENSG00000196924 |
|
melanoma |
sequence_alteration |
10.89% (11/101) |
1 entry |
ENSG00000196924 |
|
chronic myelomonocytic leukemia |
amino_acid_insertion |
3.158% (3/95) |
1 entry |
ENSG00000196924 |
|
embryonal rhabdomyosarcoma |
missense_variant |
1.316% (1/76) |
1 entry |
ENSG00000196924 |
|
breast phyllodes tumor |
amino_acid_insertion |
34.88% (30/86) |
1 entry |
ENSG00000196924 |
|
Gallbladder Adenocarcinoma |
sequence_alteration |
2.299% (2/87) |
1 entry |
ENSG00000196924 |
|
breast carcinoma |
stop_gained |
1.559% (22/1411) |
1 entry |
ENSG00000196924 |
|
ovarian mucinous adenocarcinoma |
sequence_alteration |
7.692% (1/13) |
1 entry |
ENSG00000196924 |
|
colonic neoplasm |
missense_variant |
5.556% (1/18) |
1 entry |
ENSG00000196924 |
|
colonic neoplasm |
sequence_alteration |
5.556% (1/18) |
1 entry |
ENSG00000196924 |
|
female breast carcinoma |
stop_gained |
2.247% (6/267) |
1 entry |
ENSG00000196924 |
|
endometrial carcinoma |
missense_variant |
8.696% (2/23) |
1 entry |
ENSG00000196924 |
|
large cell lung carcinoma |
missense_variant |
5.556% (1/18) |
1 entry |
ENSG00000196924 |
|
Pancreatic Acinar Cell Carcinoma |
missense_variant |
5.0% (1/20) |
1 entry |
ENSG00000196924 |
|
endometrial carcinoma |
frameshift_variant |
8.696% (2/23) |
1 entry |
ENSG00000196924 |
|
oral squamous cell carcinoma |
conservative_inframe_deletion |
2.439% (5/205) |
1 entry |
ENSG00000196924 |
|
ovarian mucinous adenocarcinoma |
missense_variant |
7.692% (1/13) |
1 entry |
ENSG00000196924 |
|
ovarian serous adenocarcinoma |
missense_variant |
0.1486% (1/673) |
1 entry |
ENSG00000196924 |
|
Fibroadenoma |
missense_variant |
2.941% (1/34) |
1 entry |
ENSG00000196924 |
|
Ampulla of Vater Carcinoma |
sequence_alteration |
2.353% (2/85) |
1 entry |
ENSG00000196924 |
|
adrenal cortex carcinoma |
sequence_alteration |
0.6098% (1/164) |
1 entry |
ENSG00000196924 |
|
basal cell carcinoma |
frameshift_variant |
20.69% (12/58) |
1 entry |
ENSG00000196924 |
|
kidney Wilms tumor |
sequence_alteration |
0.3145% (1/318) |
1 entry |
ENSG00000196924 |
|
T-cell acute lymphoblastic leukemia |
missense_variant |
0.1684% (1/594) |
1 entry |
ENSG00000196924 |
|
primary peritoneal carcinoma (disease) |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000196924 |
|
Invasive Breast Carcinoma |
missense_variant |
2.174% (1/46) |
1 entry |
ENSG00000196924 |
|
lung carcinoid tumor |
stop_gained |
9.091% (1/11) |
1 entry |
ENSG00000196924 |
|
head and neck squamous cell carcinoma |
sequence_alteration |
0.4792% (3/626) |
1 entry |
ENSG00000196924 |
|
oral squamous cell carcinoma |
stop_gained |
2.439% (5/205) |
1 entry |
ENSG00000196924 |
|
chronic lymphocytic leukemia |
missense_variant |
0.2252% (2/888) |
1 entry |
ENSG00000196924 |
|
Merkel cell skin cancer |
sequence_alteration |
10.0% (3/30) |
1 entry |
ENSG00000196924 |
|
osteosarcoma |
sequence_alteration |
1.724% (2/116) |
1 entry |
ENSG00000196924 |
|
kidney Wilms tumor |
missense_variant |
0.3145% (1/318) |
1 entry |
ENSG00000196924 |
|
bile duct adenocarcinoma |
missense_variant |
0.5291% (1/189) |
1 entry |
ENSG00000196924 |
|
mucosal melanoma |
sequence_alteration |
7.143% (1/14) |
1 entry |
ENSG00000196924 |
|
Gallbladder Adenocarcinoma |
missense_variant |
2.299% (2/87) |
1 entry |
ENSG00000196924 |
|
acute lymphoblastic leukemia |
missense_variant |
0.3115% (1/321) |
1 entry |
ENSG00000196924 |
|
laryngeal squamous cell carcinoma |
sequence_alteration |
3.846% (1/26) |
1 entry |
ENSG00000196924 |
|
Borderline Ovarian Mucinous Tumor |
missense_variant |
12.5% (1/8) |
1 entry |
ENSG00000196924 |
|
esophageal adenocarcinoma |
sequence_alteration |
0.6849% (3/438) |
1 entry |
ENSG00000196924 |
|
esophageal squamous cell carcinoma |
frameshift_variant |
2.074% (14/675) |
1 entry |
ENSG00000196924 |
|
osteosarcoma |
missense_variant |
1.724% (2/116) |
1 entry |
ENSG00000196924 |
|
embryonal rhabdomyosarcoma |
sequence_alteration |
1.316% (1/76) |
1 entry |